FDA Inspection 1024046 — Wooil C & Tech Corp.

Wooil C & Tech Corp. — FEI 3010176173

The FDA completed an inspection of Wooil C & Tech Corp. on September 1, 2017 in Pyeongtaek. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 13 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pyeongtaek (Korea (the Republic of))

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
126321 CFR 211.68(b)Computer control of master formula records
187921 CFR 211.180(c)Records not made readily available to FDA
192721 CFR 211.166(b)Accelerated stability studies
194221 CFR 211.180(e)Records reviewed annually
197521 CFR 211.182Written records kept in individual logs
202621 CFR 211.192Quality control unit review of records
203321 CFR 211.194(c)Testing and standardization of standards et. al.
203421 CFR 211.194(d)Laboratory equipment calibration records
240121 CFR 211.194(a)(4)Complete Test Data
360321 CFR 211.160(b)Scientifically sound laboratory controls
432121 CFR 211.101(b)Identification of new containers
434221 CFR 211.142(b)Storage under appropriate conditions